Cargando…
Supportive care of neurodegenerative patients
Neurodegenerative illnesses are notorious for paucity of treatments and relentless clinical progression. Illness may follow a relatively acute presentation, as is seen with primary brain tumors such as glioblastoma or have a more insidious onset with a slower yet unyielding course, such as that seen...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974138/ https://www.ncbi.nlm.nih.gov/pubmed/36865803 http://dx.doi.org/10.3389/fonc.2023.1029938 |
_version_ | 1784898673452253184 |
---|---|
author | Armitage, A. E. Fonkem, E. |
author_facet | Armitage, A. E. Fonkem, E. |
author_sort | Armitage, A. E. |
collection | PubMed |
description | Neurodegenerative illnesses are notorious for paucity of treatments and relentless clinical progression. Illness may follow a relatively acute presentation, as is seen with primary brain tumors such as glioblastoma or have a more insidious onset with a slower yet unyielding course, such as that seen in Parkinson’s disease. Though disparate in presentation, these neurodegenerative illnesses are universally terminal, and both the patients and their families benefit from the intervention of supportive care in conjunction with primary disease management. Supportive palliative care has been shown to improve quality of life, enhance patient outcomes, and often extend patient life—but such care needs to be tailored. This clinical commentary examines the role of supportive palliative care in the management of neurologic patients, comparing and contrasting glioblastoma patients with idiopathic Parkinson’s disease patients. Both patient populations are high utilizers of healthcare resources, require active management of multiple symptoms, and have high caregiver burden which underscores the need for supportive services in conjunction with disease management provided by the primary care team. Review of prognostication, patient and family communication, trust and relationship building, and complementary medicinal approaches are explored for these two diseases which broadly represent two differing poles of incurable neurological illness. |
format | Online Article Text |
id | pubmed-9974138 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99741382023-03-01 Supportive care of neurodegenerative patients Armitage, A. E. Fonkem, E. Front Oncol Oncology Neurodegenerative illnesses are notorious for paucity of treatments and relentless clinical progression. Illness may follow a relatively acute presentation, as is seen with primary brain tumors such as glioblastoma or have a more insidious onset with a slower yet unyielding course, such as that seen in Parkinson’s disease. Though disparate in presentation, these neurodegenerative illnesses are universally terminal, and both the patients and their families benefit from the intervention of supportive care in conjunction with primary disease management. Supportive palliative care has been shown to improve quality of life, enhance patient outcomes, and often extend patient life—but such care needs to be tailored. This clinical commentary examines the role of supportive palliative care in the management of neurologic patients, comparing and contrasting glioblastoma patients with idiopathic Parkinson’s disease patients. Both patient populations are high utilizers of healthcare resources, require active management of multiple symptoms, and have high caregiver burden which underscores the need for supportive services in conjunction with disease management provided by the primary care team. Review of prognostication, patient and family communication, trust and relationship building, and complementary medicinal approaches are explored for these two diseases which broadly represent two differing poles of incurable neurological illness. Frontiers Media S.A. 2023-02-14 /pmc/articles/PMC9974138/ /pubmed/36865803 http://dx.doi.org/10.3389/fonc.2023.1029938 Text en Copyright © 2023 Armitage and Fonkem https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Armitage, A. E. Fonkem, E. Supportive care of neurodegenerative patients |
title | Supportive care of neurodegenerative patients |
title_full | Supportive care of neurodegenerative patients |
title_fullStr | Supportive care of neurodegenerative patients |
title_full_unstemmed | Supportive care of neurodegenerative patients |
title_short | Supportive care of neurodegenerative patients |
title_sort | supportive care of neurodegenerative patients |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974138/ https://www.ncbi.nlm.nih.gov/pubmed/36865803 http://dx.doi.org/10.3389/fonc.2023.1029938 |
work_keys_str_mv | AT armitageae supportivecareofneurodegenerativepatients AT fonkeme supportivecareofneurodegenerativepatients |